Although epidemiological studies have long established that inorganic
arsenic is a potent human
carcinogen, the underlying mechanisms are still poorly understood. Recent studies suggest that inorganic
arsenic may act as a
tumor promoter by perturbing key signaling transduction pathways. We have shown previously that
arsenite can potently activate the
mitogen-activated protein kinase cascades and induce the expression of proliferation-associated genes, including proto-oncogenes c-jun and c-fos. In order to elucidate further the molecular mechanisms underlying its
tumor-promoting properties, we investigated the signaling events involved in
arsenite-mediated induction of c-fos and c-jun. We found that induction of both c-fos and c-jun by
arsenite can be substantially inhibited by the
MEK- selective inhibitor
U0126, suggesting that the ERK pathway is critically involved in their up-regulation. Interestingly,
arsenite dramatically induced the phosphorylation and acetylation of
histone H3 preceding the induction of mRNAs encoding c-fos and c-jun. Finally,
chromatin immunoprecipitation assays revealed that
arsenite treatment markedly induced the phosphorylation/acetylation of
histone H3 associated with the c-fos and c-jun genes through an ERK-dependent pathway. Our results strongly suggest that
arsenic-triggered alterations in
chromatin structure perturb specific gene transcription, including that of proto-oncogenes c-jun and c-fos, and may thereby contribute to the carcinogenic process.